The non-alcoholic steatohepatitis (NASH) management market is growing due to increasing cases of liver disease linked to obesity and metabolic disorders. New pharmacological treatments, lifestyle interventions, and diagnostic advancements are driving market growth through 2028. https://www.databridgemarketresearch.com/reports/global-non-alcoholic-steatohepatitis-management-market